Trial Profile
A study investigating safety and efficacy of sitagliptin in acute myocardial infarction patients with diabetes and chronic kidney disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2016
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 10 Feb 2016 New trial record